Roman Shawn David 4

What Happened
Roman Shawn David, Chief Operating Officer of Apyx Medical Corp (APYX), exercised stock options on January 27, 2026 to acquire 12,000 shares of common stock at $1.80 per share, for a cash cost of $21,600. The filing also reports the related derivative (the option) was converted/disposed in the exercise (reported at $0.00). This is an exercise of previously granted options (not a sale of the acquired shares).

Key Details

• Transaction date: January 27, 2026 (reported on Form 4 filed January 29, 2026)
• Option exercise: 12,000 shares acquired at $1.80 per share = $21,600 total (transaction code M)
• Derivative/option disposition: 12,000 reported disposed at $0.00 (conversion of the option)
• Shares owned after transaction: not specified in the provided filing summary
• Footnotes: F1 — shares are held by The Roman Family Revocable Trust (Reporting Person is trustee and beneficiary); F2 — options exercised were awarded March 16, 2016 under the Issuer’s 2015 Share Incentive Plan
• Timeliness: Filing was submitted two days after the transaction date (not indicated as late)

Context
An “M” code indicates an option exercise (conversion of a derivative into common stock). No sale of the newly acquired shares was reported on the Form 4, and the shares are reported as held by the family trust — this suggests the shares were retained rather than sold immediately. Exercises increase the insider’s actual share ownership and are informative to investors, but do not by themselves indicate a change in sentiment.